Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

The diagnosis of COPD can be frustrating for ... that group A patients receive short-acting bronchodilators, whereas group B must be given long-acting muscarinic antagonist (LAMA) or a LABA ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness ...

A total of 2,802 patients with COPD were randomised 1:1 to receive ... and could include single or dual long-acting bronchodilator therapy, inhaled corticosteroid either alone or in combination ...

Spiriva Handihaler is intended as a once-daily maintenance treatment for COPD and should not be used ... medications (including short-acting and long-acting beta-agonists, inhaled and systemic ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

and chest tightness caused by lung diseases such as asthma and chronic obstructive pulmonary disease (COPD); a group of diseases that affect the lungs and airways. It relaxes the smooth muscles in ...